Metformin in Longevity Study (MILES)
MILES was a small randomized crossover study in older adults with impaired glucose tolerance that examined transcriptomic and metabolic readouts. This source-reviewed record treats MILES as a narrow trial/evidence record, not as proof of broad metformin longevity benefit.
LN Evidence Score
3
of 5
LN Claim Risk Score
2
of 5
LN Commercial Maturity Score
0
of 5
LN Clinic Transparency Score
0
of 5